Copyright © 1998 by the European Society of Cardiology.
Eisenmenger syndrome. Factors relating to deterioration and death
a Division of Cardiology, University of Padua, Padua, Italy
b Jane Somerville Grown-up Congenital Heart Unit, Royal Bromptom Hospital and National Heart and Lung Institute, Imperial College, London, U.K.
c Humanitas Hospital, Milan, Italy
accepted March 12, 1998
Aims
To assess the natural history, risk factors for death and deterioration of patients with Eisenmenger Syndrome.
Methods
The clinical course of 188 patients from three different cardiac centres specialized in adult congenital heart defects, followed for a median period of 31 years, was retrospectively analysed. According to the diagnosis, 64 males and 124 females, mean age at last follow-up 33·02±12·8 years, were divided into two groups: simple (128) and complex (60) congenital heart disease. Events analysed were: time variation of Ability Index, pulmonary and cerebral complications, non-cardiac surgery, urate metabolism and renal function, arrhythmias, pregnancy and contraception, medical therapy and transplantation, death from all causes and sudden death.
Results
Eighty-four percent of the overall population showed a satisfactory Ability Index (1 and 2) at the first attendance (median age 25 years). Patients with complex heart disease and Eisenmenger reaction had earlier clinical deterioration (18·6±11·3 vs 26·7±12·2) and shorter survival (25·8±7·9 vs 32·5±14·6 years). Thirty-eight (20·2%) patients had at least one episode of haemoptysis between 20 and 40 years of age but it did not modify overall survival; 25 (13·2%) had pulmonary thromboembolism at a mean age of 35·2±13·4 years. Fifteen (7·9%) had a stroke and 7 (3·7%) a cerebral abscess at a mean age of 31·4±15·7 and 24·1±4·9 years, respectively. Cerebral complications influenced the quality of life but did not modify survival. Patients who had venesection showed a 2·04 times greater hazard ratio for haemoptysis. Venesection did not reduce cerebral complications and in 20% caused anaemia and iron deficiency. Other non-cardiac surgery with general anaesthesia carried risks (23·5% of deaths). Significant maternal mortality (27%) in relation to pregnancy occurred with constant deterioration in physical status, high incidence of spontaneous abortions (35·8%) and cardiac abnormalities in offspring (20%). Sixty-one patients died during follow-up, mainly by sudden death (29·5%), heart failure (22·9%) and from haemoptysis (11·4%). Eight patients had heart and lung transplantation and five died 1 week to 4 years after transplant. Deterioration in Ability Index (worsening symptoms), age, complex defects, blood creatinine level, right ventricular dysfunction and non-cardiac surgery were variables which affected the prognosis adversely with uni- and multivariate analysis.
Conclusions
patients with Eisenmenger syndrome can survive to the seventh decade with informed medical care and protection from special risks
Key Words: Eisenmenger • pulmonary vascular disease • haemoptysis • venesection
Correspondence: L. Daliento, Department of Cardiology, University of Padua Medical School, Via Giustiniani, 2, 35128 Padova, Italy.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  Authors/Task Force Members, N. Galie, M. M. Hoeper, M. Humbert, A. Torbicki, J.-L. Vachiery, J. A. Barbera, M. Beghetti, P. Corris, S. Gaine, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT) Eur. Heart J., October 2, 2009; 30(20): 2493 - 2537. [Full Text] [PDF]
|
|
|
|
 |
|
 K. Januszewska, E. Malec, G. Juchem, I. Kaczmarek, R. Sodian, P. Uberfuhr, and B. Reichart Heart-lung transplantation in patients with pulmonary atresia and ventricular septal defect J. Thorac. Cardiovasc. Surg., September 1, 2009; 138(3): 738 - 743. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Gatzoulis, R. Alonso-Gonzalez, and M. Beghetti Pulmonary arterial hypertension in paediatric and adult patients with congenital heart disease Eur. Respir. Rev., September 1, 2009; 18(113): 154 - 161. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Simonneau, I. M. Robbins, M. Beghetti, R. N. Channick, M. Delcroix, C. P. Denton, C. G. Elliott, S. P. Gaine, M. T. Gladwin, Z.-C. Jing, et al. Updated clinical classification of pulmonary hypertension. J. Am. Coll. Cardiol., June 30, 2009; 54(1 Suppl): S43 - S54. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Beghetti and N. Galie Eisenmenger syndrome a clinical perspective in a new therapeutic era of pulmonary arterial hypertension. J. Am. Coll. Cardiol., March 3, 2009; 53(9): 733 - 740. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S G Haworth and A A Hislop Treatment and survival in children with pulmonary arterial hypertension: the UK Pulmonary Hypertension Service for Children 2001-2006 Heart, February 1, 2009; 95(4): 312 - 317. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Deanfield, R. Yates, F. J. Meijboom, and B. J.M. Mulder CHAPTER 10 Congenital Heart Disease in Children and Adults ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Warnes, R. G. Williams, T. M. Bashore, J. S. Child, H. M. Connolly, J. A. Dearani, P. del Nido, J. W. Fasules, T. P. Graham Jr, Z. M. Hijazi, et al. ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease) Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons J. Am. Coll. Cardiol., December 2, 2008; 52(23): e143 - e263. [Full Text] [PDF]
|
|
|
|
|
|
C. A. Warnes, R. G. Williams, T. M. Bashore, J. S. Child, H. M. Connolly, J. A. Dearani, P. del Nido, J. W. Fasules, T. P. Graham Jr, Z. M. Hijazi, et al. ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Adults With Congenital Heart Disease) Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons J. Am. Coll. Cardiol., December 2, 2008; 52(23): 1890 - 1947. [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Warnes, R. G. Williams, T. M. Bashore, J. S. Child, H. M. Connolly, J. A. Dearani, P. del Nido, J. W. Fasules, T. P. Graham Jr, Z. M. Hijazi, et al. ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease): Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons Circulation, December 2, 2008; 118(23): e714 - e833. [Full Text] [PDF]
|
|
|
|
|
|
C. A. Warnes, R. G. Williams, T. M. Bashore, J. S. Child, H. M. Connolly, J. A. Dearani, P. del Nido, J. W. Fasules, T. P. Graham Jr, Z. M. Hijazi, et al. ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Adults With Congenital Heart Disease): Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons Circulation, December 2, 2008; 118(23): 2395 - 2451. [Full Text] [PDF]
|
|
|
|
|
|
Authors/Task Force Members, K. Dickstein, A. Cohen-Solal, G. Filippatos, J. J.V. McMurray, P. Ponikowski, P. A. Poole-Wilson, A. Stromberg, D. J. van Veldhuisen, D. Atar, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur. Heart J., October 1, 2008; 29(19): 2388 - 2442. [Full Text] [PDF]
|
|
|
|
 |
|
 K. Dickstein, A. Cohen-Solal, G. Filippatos, J. J.V. McMurray, P. Ponikowski, P. A. Poole-Wilson, A. Stromberg, D. J. van Veldhuisen, D. Atar, A. W. Hoes, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur J Heart Fail, October 1, 2008; 10(10): 933 - 989. [Full Text] [PDF]
|
|
|
|
|
|
National Pulmonary Hypertension Centres of the UK Consensus statement on the management of pulmonary hypertension in clinical practice in the UK and Ireland Heart, March 1, 2008; 94(Suppl_1): i1 - i41. [Full Text] [PDF]
|
|
|
|
 |
|
 National Pulmonary Hypertension Centres of the UK Consensus statement on the management of pulmonary hypertension in clinical practice in the UK and Ireland Thorax, March 1, 2008; 63(Suppl_2): ii1 - ii41. [Full Text] [PDF]
|
|
|
|
 |
|
 G.-P. Diller, K. Dimopoulos, H. Kafka, S. Y. Ho, and M. A. Gatzoulis Model of chronic adaptation: right ventricular function in Eisenmenger syndrome Eur. Heart J. Suppl., December 1, 2007; 9(suppl_H): H54 - H60. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. S. Broberg, M. Ujita, S. Prasad, W. Li, M. Rubens, B. E. Bax, S. J. Davidson, B. Bouzas, J. S. R. Gibbs, J. Burman, et al. Pulmonary Arterial Thrombosis in Eisenmenger Syndrome Is Associated With Biventricular Dysfunction and Decreased Pulmonary Flow Velocity J. Am. Coll. Cardiol., August 14, 2007; 50(7): 634 - 642. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Jensen, K. Iversen, N. G. Vejlstrup, and L. Sondergaard Pulmonary Artery Thrombosis and Hemoptysis in Eisenmenger Syndrome Circulation, June 19, 2007; 115(24): e632 - e634. [Full Text] [PDF]
|
|
|
|
|
|
P. M Engelfriet, M. G J Duffels, T. Moller, E. Boersma, J. G P Tijssen, E. Thaulow, M. A Gatzoulis, and B. J M Mulder Pulmonary arterial hypertension in adults born with a heart septal defect: the Euro Heart Survey on adult congenital heart disease Heart, June 1, 2007; 93(6): 682 - 687. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M D'Alto, C D Vizza, E Romeo, R Badagliacca, G Santoro, R Poscia, B Sarubbi, M Mancone, P Argiento, F Ferrante, et al. Long term effects of bosentan treatment in adult patients with pulmonary arterial hypertension related to congenital heart disease (Eisenmenger physiology): safety, tolerability, clinical, and haemodynamic effect Heart, May 1, 2007; 93(5): 621 - 625. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S C Apostolopoulou, A Manginas, D V Cokkinos, and S Rammos Long-term oral bosentan treatment in patients with pulmonary arterial hypertension related to congenital heart disease: a 2-year study Heart, March 1, 2007; 93(3): 350 - 354. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G.-P. Diller and M. A. Gatzoulis Pulmonary Vascular Disease in Adults With Congenital Heart Disease Circulation, February 27, 2007; 115(8): 1039 - 1050. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Galie, M. Beghetti, M. A. Gatzoulis, J. Granton, R. M.F. Berger, A. Lauer, E. Chiossi, M. Landzberg, and for the Bosentan Randomized Trial of Endothelin An Bosentan Therapy in Patients With Eisenmenger Syndrome: A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Circulation, July 4, 2006; 114(1): 48 - 54. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G.-P. Diller, K. Dimopoulos, C. S. Broberg, M. G. Kaya, U. S. Naghotra, A. Uebing, C. Harries, O. Goktekin, J. S. R. Gibbs, and M. A. Gatzoulis Presentation, survival prospects, and predictors of death in Eisenmenger syndrome: a combined retrospective and case-control study Eur. Heart J., July 2, 2006; 27(14): 1737 - 1742. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Sreeram Eisenmenger syndrome: towards identifying the risk factors for death Eur. Heart J., July 2, 2006; 27(14): 1644 - 1645. [Full Text] [PDF]
|
|
|
|
|
|
T. Adriaenssens, M. Delcroix, K. Van Deyk, and W. Budts Advanced therapy may delay the need for transplantation in patients with the Eisenmenger syndrome Eur. Heart J., June 2, 2006; 27(12): 1472 - 1477. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Khairy, D. W. Ouyang, S. M. Fernandes, A. Lee-Parritz, K. E. Economy, and M. J. Landzberg Pregnancy Outcomes in Women With Congenital Heart Disease Circulation, January 31, 2006; 113(4): 517 - 524. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Engelfriet, E. Boersma, E. Oechslin, J. Tijssen, M. A. Gatzoulis, U. Thilen, H. Kaemmerer, P. Moons, F. Meijboom, J. Popelova, et al. The spectrum of adult congenital heart disease in Europe: morbidity and mortality in a 5 year follow-up period: The Euro Heart Survey on adult congenital heart disease Eur. Heart J., November 1, 2005; 26(21): 2325 - 2333. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S C Apostolopoulou, A Manginas, D V Cokkinos, and S Rammos Effect of the oral endothelin antagonist bosentan on the clinical, exercise, and haemodynamic status of patients with pulmonary arterial hypertension related to congenital heart disease Heart, November 1, 2005; 91(11): 1447 - 1452. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Moons, K. Van Deyk, K. Marquet, E. Raes, L. De Bleser, W. Budts, and S. De Geest Individual quality of life in adults with congenital heart disease: a paradigm shift Eur. Heart J., February 1, 2005; 26(3): 298 - 307. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Task Force members, N. Galie, A. Torbicki, R. Barst, P. Dartevelle, S. Haworth, T. Higenbottam, H. Olschewski, A. Peacock, G. Pietra, et al. Guidelines on diagnosis and treatment of pulmonary arterial hypertension: The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology Eur. Heart J., December 2, 2004; 25(24): 2243 - 2278. [Full Text] [PDF]
|
|
|
|
|
|
C Broberg, M Ujita, S Babu-Narayan, M Rubens, S K Prasad, J S R Gibbs, and M A Gatzoulis Massive pulmonary artery thrombosis with haemoptysis in adults with Eisenmenger's syndrome: a clinical dilemma Heart, November 1, 2004; 90(11): e63 - e63. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Moons, K. Van Deyk, W. Budts, and S. De Geest Caliber of Quality-of-Life Assessments in Congenital Heart Disease: A Plea for More Conceptual and Methodological Rigor Arch Pediatr Adolesc Med, November 1, 2004; 158(11): 1062 - 1069. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. F. Corno, Y. Boone, I. Mallabiabarrena, M. Augstburger, P. Tozzi, E. Ferrari, and L. K. von Segesser Myocardial and pulmonary effects of aqueous oxygen with acute hypoxia Ann. Thorac. Surg., September 1, 2004; 78(3): 956 - 960. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. F. Corno, Y. Boone, I. Mallabiabarrena, M. Augstburger, and L. K. von Segesser Aqueous oxygen: the solution to relief hypoxic pulmonary hypertension Eur. J. Cardiothorac. Surg., August 1, 2004; 26(2): 301 - 305. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. T. Lovell Anaesthetic implications of grown-up congenital heart disease Br. J. Anaesth., July 1, 2004; 93(1): 129 - 139. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Simonneau, N. Galie, L. J. Rubin, D. Langleben, W. Seeger, G. Domenighetti, S. Gibbs, D. Lebrec, R. Speich, M. Beghetti, et al. Clinical classification of pulmonary hypertension J. Am. Coll. Cardiol., June 16, 2004; 43(12_Suppl_S): 5S - 12S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. R. Heller, R. J. Litz, and T. Koch A fine balance--one-lung ventilation in a patient with Eisenmenger syndrome Br. J. Anaesth., April 1, 2004; 92(4): 587 - 590. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. K. Silversides, J. T. Granton, E. Konen, M. A. Hart, G. D. Webb, and J. Therrien Pulmonary thrombosis in adults with Eisenmenger syndrome J. Am. Coll. Cardiol., December 3, 2003; 42(11): 1982 - 1987. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G R Veldtman, J A Dearani, and C A Warnes Low pressure giant pulmonary artery aneurysms in the adult: natural history and management strategies Heart, September 1, 2003; 89(9): 1067 - 1070. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
The Task Force on the Management of Grown Up Conge, Task Force members, J. Deanfield, E. Thaulow, C. Warnes, G. Webb, F. Kolbel, A. Hoffman, K. Sorenson, H. Kaemmerer, et al. Management of Grown Up Congenital Heart Disease Eur. Heart J., June 1, 2003; 24(11): 1035 - 1084. [Full Text] [PDF]
|
|
|
|
|
|
A. F. Corno, P. Tozzi, C. Y. Genton, and L. K. von Segesser Surgically induced unilateral pulmonary hypertension: time-related analysis of a new experimental model Eur. J. Cardiothorac. Surg., April 1, 2003; 23(4): 513 - 517. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Galie, A. Manes, and A. Branzi The new clinical trials on pharmacological treatment in pulmonary arterial hypertension Eur. Respir. J., October 1, 2002; 20(4): 1037 - 1049. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. Stoica, K. D. McNeil, K. Perreas, L. D. Sharples, D. K. Satchithananda, S. S. Tsui, S. R. Large, and J. Wallwork Heart-lung transplantation for Eisenmenger syndrome: early and long-term results Ann. Thorac. Surg., December 1, 2001; 72(6): 1887 - 1891. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. SANDOVAL, J. S. AGUIRRE, T. PULIDO, M. L. MARTINEZ-GUERRA, E. SANTOS, P. ALVARADO, M. ROSAS, and E. BAUTISTA Nocturnal Oxygen Therapy in Patients with the Eisenmenger Syndrome Am. J. Respir. Crit. Care Med., November 1, 2001; 164(9): 1682 - 1687. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
British Cardiac Society Guidelines and Medical Pra Recommendations on the management of pulmonary hypertension in clinical practice Heart, September 1, 2001; 86(90001): i1 - 13. [Full Text] [PDF]
|
|
|
|
|
|
H Oya, N Nagaya, T Satoh, F Sakamaki, S Kyotani, M Fujita, N Nakanishi, and K Miyatake Haemodynamic correlates and prognostic significance of serum uric acid in adult patients with Eisenmenger syndrome Heart, July 1, 2000; 84(1): 53 - 58. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B.M Weiss and O.M Hess Pulmonary vascular disease and pregnancy: current controversies, management strategies, and perspectives Eur. Heart J., January 2, 2000; 21(2): 104 - 115. [PDF]
|
|